Lung Cancer

Health Condition

Lung Cancer Prevention

  • Beta-Carotene

    Beta-carotene supplementation appears to reduce cancer risk in nonsmokers. Smokers should avoid beta-carotene supplements, including the amounts found in multivitamins.

    Dose:

    Refer to label instructions
    Beta-Carotene
    ×

    In double-blind trials, synthetic beta-carotene supplementation has led to an increased risk of lung cancer in smokers,1,2 though not in groups consisting primarily of nonsmokers.3 Smokers should avoid synthetic beta-carotene supplements, including the relatively small amounts found in many multivitamins.

    The researchers who conducted the lung cancer trials have been criticized for not having used the natural form of beta-carotene.4 Preliminary evidence suggests that natural beta-carotene supplementation results in better antioxidant activity5 and anticancer activity in humans6 than does supplementation with synthetic beta-carotene. Nonetheless, much less is known about natural beta-carotene and questions remain about its potential efficacy.7 The effect of natural beta-carotene supplementation on lung cancer risk has yet to be studied.

    The strong association between increased intake of beta-carotene from food and a reduced risk of lung cancer8 does not necessarily mean that supplementation with natural beta-carotene supplements would reduce the risk of lung cancer. Dietary beta-carotene may be a marker for diets high in certain fruits and vegetables that contain other anticancer substances that may be responsible for the protective effects. Until more is known, some doctors advise smokers to avoid all forms of beta-carotene supplementation—even natural beta-carotene.

  • Selenium

    Selenium, reported to have diverse anticancer actions, has been shown in one study to reduce lung cancer incidence.

    Dose:

    200 mcg daily
    Selenium
    ×

    Selenium has been reported to have diverse anticancer actions.9,10 Selenium inhibits cancer growth in animals.11 Low soil levels of selenium (probably associated with low dietary intake), have been associated with increased cancer incidence in humans.12 Blood levels of selenium have been reported to be low in patients with many cancers,13,14,15,16,17,18,19,20 including lung cancer.21 In preliminary reports, people with the lowest blood levels of selenium had between 3.8 and 5.8 times the risk of dying from cancer compared with those who had the highest selenium levels.22,23

    The strongest evidence supporting the anticancer effects of selenium supplementation comes from a double-blind trial of 1,312 Americans with a history of skin cancer who were treated with 200 mcg of yeast-based selenium per day or a placebo for 4.5 years and then followed for an additional two years.24 Although no decrease in skin cancers occurred, a 50% reduction in overall cancer deaths and a 37% reduction in total cancer incidence was observed. A 46% decrease in lung cancer incidence and a 53% drop in deaths from lung cancer also occurred. These findings were all statistically significant.

  • Vitamin E

    High vitamin E levels have been associated with a reduced lung cancer risk. In one trial, nonsmokers who took vitamin E had a 45% lower lung cancer risk compared with those who did not take the vitamin.

    Dose:

    200 to 400 IU daily
    Vitamin E
    ×

    Relatively high blood levels25,26 and dietary levels27 of vitamin E have been associated with a reduced risk of lung cancer. In a preliminary trial, nonsmokers who took vitamin E supplements had a 45% lower risk of lung cancer compared with nonsmokers who did not supplement with vitamin E.28 While a double-blind trial reported that vitamin E supplementation had no effect on lung cancer risk,29 the amount used—approximately 50 IU per day—may have been too low to have a significant effect.

     
  • Conjugated Linoleic Acid

    Preliminary research suggests that CLA might reduce the risk of cancers at several sites, including breast, prostate, colorectal, lung, skin, and stomach.

    Dose:

    Refer to label instructions
    Conjugated Linoleic Acid
    ×
     

    Preliminary animal and test tube research suggests that conjugated linoleic acid might reduce the risk of cancers at several sites, including breast, prostate, colorectal, lung, skin, and stomach.30,31,32,33

  • Folic Acid

    Together, folic acid and vitamin B12 help cells replicate normally. In one trial, smokers with precancerous lung changes who were given folic acid and vitamin B12 saw a significant reversal of their condition.

    Dose:

    Refer to label instructions
    Folic Acid
    ×
     

    Folic acid and vitamin B12 work together in the body to help cells replicate normally. In a double-blind trial, smokers with precancerous changes in the lungs were given a placebo or the combination of 10,000 mcg of folic acid and 500 mcg of vitamin B12 per day for four months.34 A significant reversal of precancerous changes occurred in those given vitamin supplements compared with those given the placebo.34 No trials have investigated whether either vitamin given alone or the combination of both vitamins would help to treat people who already have lung cancer.

  • Green Tea

    Numerous preliminary studies have shown an association between drinking green tea and a reduced risk of several types of cancer including lung cancer.

    Dose:

    Refer to label instructions
    Green Tea
    ×
     

    Numerous preliminary studies have shown an association between drinking green tea and a reduced risk of several types of cancer35,36,37,38 including lung cancer.39 In contrast, preliminary studies of black tea consumption have not found that it protected against any type of cancer.40,41,42

  • Vitamin B12

    Together, folic acid and vitamin B12 help cells replicate normally. In one trial, smokers with precancerous lung changes who were given folic acid and vitamin B12 saw a significant reversal of their condition.

    Dose:

    Refer to label instructions
    Vitamin B12
    ×
    Folic acid and vitamin B12 work together in the body to help cells replicate normally. In a double-blind trial, smokers with precancerous changes in the lungs were given a placebo or the combination of 10,000 mcg of folic acid and 500 mcg of vitamin B12 per day for four months.43 A significant reversal of precancerous changes occurred in those given vitamin supplements compared with those given the placebo.43
What Are Star Ratings
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

References

1. Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550-9.

2. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.

3. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.

4. Doering W von E. Antioxidant vitamins, cancer and cardiovascular disease. N Engl J Med 1996;335:1065 [letter].

5. Ben-Amotz A, Levy Y. Bioavailability of a natural isomer mixture compared with synthetic all-transß-carotene in human serum. Am J Clin Nutr 1996;63:729-34.

6. Yeum KJ, Azhu S, Xiao S, et al. Beta-carotene intervention trial in premalignant gastric lesions. J Am Coll Nutr 1995;14:536 [abstr #48].

7. Johnson EJ, Krinsky NI, Russell RM. Serum response of all-trans and 9-cis isomers of ß-carotene in humans. J Am Coll Nutr1996;15:620-4.

8. Shekelle RB, Lepper M, Liu S, et al. Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet 1981;2:1185-90.

9. Medina D. Mechanisms of selenium inhibition of tumorigenesis. Adv Exp Med Biol 1986;206:465-72.

10. Beisel WR. Single nutrients and immunity. Am J Clin Nutr 1982;35:417-68.

11. Medina D, Morrison DG. Current ideas on selenium as a chemopreventative agent. Pathol Immunopathol Res 1988;7:187-99.

12. Shamberger RJ, Rukoven E, Lonfield AK, et al. Antioxidants and cancer. I. Selenium in the blood of normals and cancer patients. J Natl Cancer Inst 1973;4:863-70.

13. Burney PGJ, Comstock GW, Morris JS. Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 1989;49:895-900.

14. Toma S, Micheletti A, Giacchero A, et al. Selenium therapy in patients with precancerous and malignant oral cavity lesions: preliminary results. Cancer Detection Prev 1991;15:491-3.

15. Willett WC, Polk BF, Morris JS, et al. Prediagnostic serum Selenium and risk of cancer. Lancet 1983;42:130-4.

16. Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, alpha-tocopherol, ß-carotene, retinol, and subsequent bladder cancer. Cancer Res 1989;49:6144-8.

17. Jaskiewicz K, Marasas WF, Rossouw JE, et al. Selenium and other mineral elements in populations at risk for esophageal cancer. Cancer 1988;62:2635-9.

18. Knekt P, Aromaa A, Maatela J, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 1990;82:864-8.

19. Yu M-W, Horng I-S, Hsu K-H, et al. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol 1999;150:367-74.

20. Scieszka M, Danch A, Machalski M, Drozdz M. Plasma selenium concentration in patients with stomach and colon cancer in the Upper Silesia. Neoplasma 1997;44:395-7.

21. Knekt P, Marniemi J, Teppo L, et al. Is low selenium status a risk factor for lung cancer? Am J Epidemiol 148:975-82.

22. Fex G, Pettersson B, Akesson B. Low plasma selenium as a risk factor for cancer death in middle-aged men. Nutr Cancer 1987;10:221-9.

23. Salonen J, Salonen R, Lappetelainen R, et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E; matched case-control analysis of prospective data. BMJ 1985;290:417-20.

24. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996;276:1957-63.

25. Menkes MS, Comstock GW, Vuilleumier JP, et al. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 1986;315:1250-4.

26. Eichholzer M, Stahelin HB, Gey F, et al. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel Study. Int J Cancer 1996;66:145-50.

27. Knekt P. Vitamin E and smoking and the risk of lung cancer. Ann NY Acad Sci 1993;686:280-7; discussion 287-8.

28. Mayne ST, Janerich DT, Greenwald P, et al. Dietary beta carotene and lung cancer risk in U.S. nonsmokers. J Natl Cancer Inst 1994;86:33-8.

29. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.

30. Cesano A, Visonneau S, Scimeca JA, et al. Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res 1998;18:1429-34.

31. Thompson H, Zhu Z, Banni S, et al. Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk. Cancer Res 1997;57:5067-72.

32. Ip C. Review of the effects of trans fatty acids, oleic acid, n-3 polyunsaturated fatty acids, and conjugated linoleic acid on mammary carcinogenesis in animals. Am J Clin Nutr 1997;66(suppl):1523S-29S [review].

33. Parodi PW. Cows' milk fat components as potential anticarcinogenic agents. J Nutr 1997;127:1055-60 [review].

34. Heimburger DC, Alexander B, Birch R, et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 1988;259:1525-30.

35. Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res 1988;79:1067-74.

36. Gao YT, McLaughlin JK, Blot WJ, et al. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 1994;86:855-8.

37. Ji BT, Chow WH, Hsing AW, et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 1997;70:255-8.

38. Fujiki H. Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 1999;125:589-97 [review].

39. Ohno Y, Wakai K, Genka K, et al. Tea consumption and lung cancer risk: A case-control study in Okinawa, Japan. Jpn J Cancer Res 1995;86:1027-34.

40. Goldbohm RA, Hertog MGL, Brants HAM, et al. Consumption of black tea and cancer risk: A prospective cohort study. J Natl Cancer Inst 1996;88:93-100.

41. Heilbrun L, Nomura A, Stemmermann G. Black tea consumption and cancer risk: A prospective study. Br J Cancer 1986;54:677-83.

42. Phillips RL, Snowdon DA. Dietary relationship with fatal colorectal cancer among Seven-Day Adventists. J Natl Cancer Inst 1985;74:307-17.

43. Heimburger DC, Alexander B, Birch R, et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 1988;259:1525-30.

44. Pierce RJ, Kune GA, Kune S, et al. Dietary and alcohol intake, smoking pattern occupational risk, and family history in lung cancer patients: results of a case-control study in males. Nutr Cancer 1989;12:237-48.

45. Rose DP, Connolley JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999;83:217-44.

46. Eichholzer M. Ernahrung und Krebs. Ther Umsch 2000;57:146-51 [review in German].

47. Le Marchand L, Murphy SP, Hankin JH, et al. Intake of flavonoids and lung cancer. J Natl Cancer Inst 2000;92:154-60.

48. Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997;146:223-30.

49. Hertog MGL, Kromhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995;155:381-6.

50. Sinha R, Kulldorff M, Curtin J, et al. Fried, well-done red meat and risk of lung cancer in women (United States). Cancer Causes Control 1998;9:621-30.

51. Deneco-Pellegrini H, De Stefani E, Ronco A, et al. Meat consumption and risk of lung cancer; a case-control study from Uruguay. Lung Cancer 1996;14:195-205.

52. Mohr DL, Blot WJ, Tousey PM, et al. Southern cooking and lung cancer. Nutr Cancer 1999;35:34-43 [review].

53. Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either a-carotene or ß-carotene. Nutr Cancer 1995;24:257-66.

54. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317-31.

55. De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, et al. Dietary fat and lung cancer: a case-control study in Uruguay. Cancer Causes Control 1997;8:913-21.

56. Hinds MW, Kolonel LN, Hankin JH, Lee J. Dietary cholesterol and lung cancer risk in a multiethnic population in Hawaii. Int J Cancer 1983;32:727-32.

57. Shekelle RB, Rossof AH, Stamler J. Dietary cholesterol and incidence of lung cancer: the Western Electric Study. Am J Epidemiol 1991;134:480-4.

58. Wu Y, Zheng W, Sellers TA, et al. Dietary cholesterol, fat, and lung cancer incidence among older women: the Iowa Women's Health Study (United States). Cancer Causes Control 1994;5:395-400.

59. Wynder EL, Herbert JR, Kabat GC. Association of dietary fat and lung cancer. J Natl Cancer Inst 1987;79:631-7.

60. De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, et al. Dietary fat and lung cancer: a case-control study in Uruguay. Cancer Causes Control 1997;8:913-21.

61. Wu Y, Zheng W, Sellers TA, et al. Dietary cholesterol, fat, and lung cancer incidence among older women: the Iowa Women's Health Study (United States). Cancer Causes Control 1994;5:395-400.

62. Alavanja MCR, Brown CC, Swanson C, Brownson RC. Saturated fat intake and lung cancer risk among nonsmoking women in Missouri. J Natl Cancer Inst 1993;85:1906-16.

63. Alavanja MCR, Swansons C, Brown C, Brownson R. Re: Lung cancer: another consequence of a high-fat diet? J Natl Cancer Inst 1994;86:314 [letter].

64. Veierod MB, Laake P, Thelle DS. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev 1997;6:540-9.

65. De Stefani E, Deneo-Pellegrini H, Mendilaharsu M, et al. Dietary sugar and lung cancer: a case-control study in Uruguay. Nutr Cancer 1998;31:132-7.

66. Murphy GP, Lawrence W, Lenhard RE (eds). American Cancer Society Textbook of Clinical Oncology, second edition. Atlanta: American Cancer Society, Inc., 1995, 221 [review].

67. Zhong L, Goldberg MS, Parent ME, Hanley JA. Exposure to environmental tobacco smoke and the risk of lung cancer: a meta-analysis. Lung Cancer 2000;27:3-18.

68. Lubin JR, Boice JD Jr. Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. J Natl Cancer Inst 1997;89:49-57.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.

drug Image
Check Pricing on Drugs Commonly Used to Treat lung cancer:

Select drug name to view medication information and pricing.

Log In

You need to log into the site to use this feature

Create A Free Account To Use Medicine Chest

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use Medicine Chest

Create A Free Account To Use this feature

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use this feature

You will be redirected to your program in 5 seconds.

Hi there.

Our Terms and Conditions and Privacy Policy have recently been updated.

Learn More


I Accept

By declining you will be logged out of your account

;